img

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Adjuvanted Influenza Vaccine Market Research Report 2024

An adjuvanted influenza vaccine is a type of influenza vaccine that has a substance called an "adjuvant" added during the vaccine preparation process. Adjuvant is a substance that can enhance the immune response. It can improve the response of the immune system to vaccine components (such as viral antigens) after vaccination, thereby increasing the effect of immune protection.
According to Mr Accuracy reports’s new survey, global Adjuvanted Influenza Vaccine market is projected to reach US$ 2176.1 million in 2029, increasing from US$ 952.3 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029.
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adjuvanted Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


CSL
Segment by Type
Vial
Prefilled

Segment by Application


Public Sector
Private Sector

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Adjuvanted Influenza Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Adjuvanted Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Adjuvanted Influenza Vaccine
1.2 Adjuvanted Influenza Vaccine Segment by Type
1.2.1 Global Adjuvanted Influenza Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Vial
1.2.3 Prefilled
1.3 Adjuvanted Influenza Vaccine Segment by Application
1.3.1 Global Adjuvanted Influenza Vaccine Market Value by Application: (2024-2034)
1.3.2 Public Sector
1.3.3 Private Sector
1.4 Global Adjuvanted Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Adjuvanted Influenza Vaccine Revenue 2018-2029
1.4.2 Global Adjuvanted Influenza Vaccine Sales 2018-2029
1.4.3 Global Adjuvanted Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Adjuvanted Influenza Vaccine Market Competition by Manufacturers
2.1 Global Adjuvanted Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Adjuvanted Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Adjuvanted Influenza Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Adjuvanted Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Adjuvanted Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adjuvanted Influenza Vaccine, Product Type & Application
2.7 Adjuvanted Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Adjuvanted Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Adjuvanted Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Adjuvanted Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Adjuvanted Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Adjuvanted Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Adjuvanted Influenza Vaccine Global Adjuvanted Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Adjuvanted Influenza Vaccine Sales by Region: 2018-2024
3.2.2 Global Adjuvanted Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Adjuvanted Influenza Vaccine Global Adjuvanted Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Adjuvanted Influenza Vaccine Revenue by Region: 2018-2024
3.3.2 Global Adjuvanted Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Adjuvanted Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Adjuvanted Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Adjuvanted Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Adjuvanted Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adjuvanted Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Adjuvanted Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Adjuvanted Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Adjuvanted Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adjuvanted Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Adjuvanted Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Adjuvanted Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Adjuvanted Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adjuvanted Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Adjuvanted Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Adjuvanted Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Adjuvanted Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adjuvanted Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Adjuvanted Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Adjuvanted Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Adjuvanted Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adjuvanted Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Adjuvanted Influenza Vaccine Sales by Type (2018-2024)
4.1.2 Global Adjuvanted Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Adjuvanted Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Adjuvanted Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Adjuvanted Influenza Vaccine Revenue by Type (2018-2024)
4.2.2 Global Adjuvanted Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Adjuvanted Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Adjuvanted Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Adjuvanted Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Adjuvanted Influenza Vaccine Sales by Application (2018-2024)
5.1.2 Global Adjuvanted Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Adjuvanted Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Adjuvanted Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Adjuvanted Influenza Vaccine Revenue by Application (2018-2024)
5.2.2 Global Adjuvanted Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Adjuvanted Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Adjuvanted Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Adjuvanted Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 CSL Adjuvanted Influenza Vaccine Product Portfolio
6.1.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adjuvanted Influenza Vaccine Industry Chain Analysis
7.2 Adjuvanted Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adjuvanted Influenza Vaccine Production Mode & Process
7.4 Adjuvanted Influenza Vaccine Sales and Marketing
7.4.1 Adjuvanted Influenza Vaccine Sales Channels
7.4.2 Adjuvanted Influenza Vaccine Distributors
7.5 Adjuvanted Influenza Vaccine Customers
8 Adjuvanted Influenza Vaccine Market Dynamics
8.1 Adjuvanted Influenza Vaccine Industry Trends
8.2 Adjuvanted Influenza Vaccine Market Drivers
8.3 Adjuvanted Influenza Vaccine Market Challenges
8.4 Adjuvanted Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Adjuvanted Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Adjuvanted Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Adjuvanted Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Adjuvanted Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Adjuvanted Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Adjuvanted Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Adjuvanted Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Adjuvanted Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Adjuvanted Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adjuvanted Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Adjuvanted Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adjuvanted Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvanted Influenza Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adjuvanted Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Adjuvanted Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Adjuvanted Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Adjuvanted Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Adjuvanted Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Adjuvanted Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Adjuvanted Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Adjuvanted Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Adjuvanted Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Adjuvanted Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Adjuvanted Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Adjuvanted Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Adjuvanted Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Adjuvanted Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Adjuvanted Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Adjuvanted Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Adjuvanted Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Adjuvanted Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Adjuvanted Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Adjuvanted Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Adjuvanted Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Adjuvanted Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Adjuvanted Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Adjuvanted Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Adjuvanted Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Adjuvanted Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Adjuvanted Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Adjuvanted Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Adjuvanted Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Adjuvanted Influenza Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Adjuvanted Influenza Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Adjuvanted Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Adjuvanted Influenza Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Adjuvanted Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Adjuvanted Influenza Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Adjuvanted Influenza Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Adjuvanted Influenza Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Adjuvanted Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Adjuvanted Influenza Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Adjuvanted Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. CSL Corporation Information
Table 71. CSL Description and Business Overview
Table 72. CSL Adjuvanted Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. CSL Adjuvanted Influenza Vaccine Product
Table 74. CSL Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Adjuvanted Influenza Vaccine Distributors List
Table 78. Adjuvanted Influenza Vaccine Customers List
Table 79. Adjuvanted Influenza Vaccine Market Trends
Table 80. Adjuvanted Influenza Vaccine Market Drivers
Table 81. Adjuvanted Influenza Vaccine Market Challenges
Table 82. Adjuvanted Influenza Vaccine Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Adjuvanted Influenza Vaccine
Figure 2. Global Adjuvanted Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Adjuvanted Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Vial Product Picture
Figure 5. Prefilled Product Picture
Figure 6. Global Adjuvanted Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Adjuvanted Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. Public Sector
Figure 9. Private Sector
Figure 10. Global Adjuvanted Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Adjuvanted Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Adjuvanted Influenza Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Adjuvanted Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Adjuvanted Influenza Vaccine Report Years Considered
Figure 15. Adjuvanted Influenza Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Adjuvanted Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Adjuvanted Influenza Vaccine Players: Market Share by Revenue in 2022
Figure 18. Adjuvanted Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Adjuvanted Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Adjuvanted Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Adjuvanted Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Adjuvanted Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Adjuvanted Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Adjuvanted Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Adjuvanted Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Adjuvanted Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 41. Latin America Adjuvanted Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Colombia Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Adjuvanted Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Adjuvanted Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Adjuvanted Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Adjuvanted Influenza Vaccine by Type (2018-2029)
Figure 52. Global Revenue Market Share of Adjuvanted Influenza Vaccine by Type (2018-2029)
Figure 53. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Adjuvanted Influenza Vaccine by Application (2018-2029)
Figure 55. Global Revenue Market Share of Adjuvanted Influenza Vaccine by Application (2018-2029)
Figure 56. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 57. Adjuvanted Influenza Vaccine Value Chain
Figure 58. Adjuvanted Influenza Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries